Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 182,662,800
  • Shares Outstanding, K 1,735,184
  • Annual Sales, $ 40,109 M
  • Annual Income, $ 5,723 M
  • 60-Month Beta 0.74
  • Price/Sales 4.58
  • Price/Cash Flow 17.17
  • Price/Book 4.88
Trade ABT with:

Options Overview Details

View History
  • Implied Volatility 19.68% ( -0.21%)
  • Historical Volatility 20.09%
  • IV Percentile 56%
  • IV Rank 25.29%
  • IV High 32.46% on 10/12/23
  • IV Low 15.35% on 07/28/23
  • Put/Call Vol Ratio 0.48
  • Today's Volume 24,436
  • Volume Avg (30-Day) 14,674
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 236,869
  • Open Int (30-Day) 206,965

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 1.11
  • Number of Estimates 5
  • High Estimate 1.12
  • Low Estimate 1.10
  • Prior Year 1.08
  • Growth Rate Est. (year over year) +2.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.25 +2.91%
on 04/17/24
114.02 -5.91%
on 03/28/24
-5.88 (-5.20%)
since 03/19/24
3-Month
104.25 +2.91%
on 04/17/24
121.64 -11.81%
on 03/08/24
-7.41 (-6.46%)
since 01/19/24
52-Week
89.67 +19.63%
on 10/12/23
121.64 -11.81%
on 03/08/24
-5.01 (-4.46%)
since 04/19/23

Most Recent Stories

More News
Quiver Markets Wrap: S&P 4 Day Losing Streak

Wall Street's main indexes faltered, marking their longest slump since January as investors grappled with a mix of rising bond yields and a tech sector sell-off, primarily led by significant losses in...

NVDA : 762.00 (-10.00%)
MS : 90.66 (+0.44%)
JPM : 185.80 (+2.51%)
WFC : 60.35 (+2.74%)
UAL : 51.38 (-0.08%)
UBS : 28.06 (-0.21%)
ABT : 107.28 (+1.91%)
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript

ABT earnings call for the period ending March 31, 2024.

ABT : 107.28 (+1.91%)
Quiver Morning Wrap

Wall Street struggled to find footing on Wednesday, with the major indexes closing in the red as downbeat earnings and a downturn in chip stocks added to the market's woes. The Philadelphia Semiconductor...

NVDA : 762.00 (-10.00%)
JBHT : 167.30 (+1.89%)
USB : 40.45 (+2.56%)
ABT : 107.28 (+1.91%)
UAL : 51.38 (-0.08%)
AAL : 14.11 (+0.64%)
DAL : 47.57 (-0.59%)
LUV : 29.38 (+1.10%)
PLD : 103.49 (-1.15%)
TRV : 214.07 (+1.73%)
SPY : 495.16 (-0.87%)
QQQ : 414.65 (-2.07%)
Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range

Abbott Laboratories on Wednesday reported first-quarter profit of $1.23 billion

ABT : 107.28 (+1.91%)
Abbott Labs Beats Earnings Estimates Due To Medical Device Sales

Abbott Laboratories (ABT) beat Wall Street estimates for its first quarter financial results due to ...

ABT : 107.28 (+1.91%)
Abbott: Q1 Earnings Snapshot

Abbott: Q1 Earnings Snapshot

ABT : 107.28 (+1.91%)
S&P Futures Climb as Investors Shift Focus to Earnings

June S&P 500 E-Mini futures (ESM24) are trending up +0.39% this morning as market participants moved past hawkish comments from Federal Reserve Chair Jerome Powell and looked ahead to the next round of...

ESM24 : 5,003.75s (-0.90%)
LYV : 89.96 (+0.36%)
BAC : 36.97 (+3.35%)
JNJ : 147.91 (+1.49%)
SMCI : 713.65 (-23.14%)
UNH : 501.13 (+1.61%)
ABT : 107.28 (+1.91%)
USB : 40.45 (+2.56%)
KMI : 18.84 (+3.46%)
LVS : 45.46 (-0.92%)
CSX : 34.34 (-0.15%)
ASML.NA : 821.000 (-2.30%)
Insiders, hedge funds, and politicians trading Abbott Laboratories stock (NYSE:ABT) in Q1 2024

$ABT earnings are coming up. Here is a look at recent trades of $ABT by people who might have an edge.CongressMembers of Congress have disclosed trades of $ABT stock 3 times in the last quarter. Of those...

ABT : 107.28 (+1.91%)
Stocks Set to Open Higher as Iran-Israel Tensions Ease, Earnings and Fed Speak in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.44%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.52% this morning as market participants wagered that tensions in the Middle East won’t escalate...

ESM24 : 5,003.75s (-0.90%)
NQM24 : 17,180.75s (-2.09%)
ANET : 246.09 (-4.32%)
INTC : 34.20 (-2.40%)
AMD : 146.64 (-5.44%)
JPM : 185.80 (+2.51%)
GS : 404.00 (+0.22%)
BAC : 36.97 (+3.35%)
MS : 90.66 (+0.44%)
NFLX : 555.04 (-9.09%)
UNH : 501.13 (+1.61%)
JNJ : 147.91 (+1.49%)
Wholesale, Inflation Figures in Canada Due Next Week

Monday U.S. Economic Lookahead Retail Sales (March) Business inventories (Feb.) ...

ABT : 107.28 (+1.91%)
PLD : 103.49 (-1.15%)
ELV : 531.42 (+1.19%)
GS.TO : 14.24 (-0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 110.63
2nd Resistance Point 109.20
1st Resistance Point 108.24
Last Price 107.28
1st Support Level 105.85
2nd Support Level 104.42
3rd Support Level 103.46

See More

52-Week High 121.64
Fibonacci 61.8% 109.43
Last Price 107.28
Fibonacci 50% 105.66
Fibonacci 38.2% 101.89
52-Week Low 89.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar